Who We Are
ZeGen Therapeutics is a patient-centric clinical stage biopharmaceutical company focused on developing and commercializing novel gene therapies for developmental epileptic disorders.
By combining our founders and management team’s proven experience in gene therapy drug development and commercialization with MU’s world-class gene therapy research capabilities, we believe we have created a powerful technology platform to develop transformative therapies to dramatically improve patients’ lives.
Our mission is to improve human health and quality of life by developing innovative gene therapies for treating and possibly reversing the effects of hard-to-treat diseases such as rare developmental and epileptic encephalopathies.
